1. Richardson P, Guinan E. The pathology, diagnosis, and treatment of hepatic veno‐occlusive disease: current status and novel approaches. British journal of haematology. 1999;107(3):485–93. doi: 10.1046/j.1365-2141.1999.01680.x 10583247
2. Bearman S. Avoiding hepatic veno-occlusive disease: what do we know and where are we going? Bone marrow transplantation. 2001;27(11):1113. 11551020
3. Coppell JA, Brown SA, Perry DJ. Veno-occlusive disease: cytokines, genetics, and haemostasis. Blood Reviews. 2003;17(2):63–70. 12642120
4. T.Orfanidis N. Veno-occulusive disease of the liver 2016.
5. Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood. 1995;85(11):3005–20. 7756636
6. Altaee MY. An outbreak of veno-occlusive disease of the liver in northern Iraq. 1998.
7. Carreras EGA, Rozman C. hepatic veno-occulusive disease after bone marrow transplant. Blood Reviews. 1993;7:43–51. 8467232
8. Chen Z, Huo J-R. Hepatic veno-occlusive disease associated with toxicity of pyrrolizidine alkaloids in herbal preparations. Neth J Med. 2010;68(6):252–60. 20558855
9. Senzolo M, Germani G, Cholongitas E, Burra P, Burroughs A. Veno occlusive disease: update on clinical management. World journal of gastroenterology: WJG. 2007;13(29):3918 17663504
10. Kakar F, Akbarian Z, Leslie T, Mustafa ML, Watson J, van Egmond HP, et al. An outbreak of hepatic veno-occlusive disease in Western Afghanistan associated with exposure to wheat flour contaminated with pyrrolizidine alkaloids. Journal of toxicology. 2010;2010.
11. Tandon BN, Tandon H, Tandon R, Narndranathan M, Joshi Y. An epidemic of veno-occlusive disease of liver in central India. The Lancet. 1976;308(7980):271–2.
12. Chiu C, Buttke D, Welde G, Luce R, Debela A, Bitew A, et al. Evaluation of the Pyrrolizidine Alkaloid Induced Liver Disease (PAILD) Active Surveillance System in Tigray, Ethiopia. 2013.
13. Debella A, Abebe D, Tekabe F, Mamo H, Abebe A, Tsegaye B, et al. Toxicity study and evaluation of biochemical markers towards the identification of the causative agent for an outbreak of liver disease in Tahtay Koraro Woreda, Tigray. Ethiopian medical journal. 2012;50:27–35. 22946293
14. Mesfin G, Ali A, Seboxa T, Bane A, Tensae MW, Gebressilassie S, et al. An epidemiological study into the investigation of liver disease of unknown origin in a rural community of northern Ethiopia, 2005. Ethiopian medical journal. 2012:1–8.
15. Abebe D, Debella A, Tekabe F, Mekonnen Y, Degefa A, Mekonnen A, et al. An outbreak of liver disease in Tahtay Koraro Woreda, Tigray region of Ethiopia: a case-control study for the identification of the etiologic agent. Ethiopian medical journal. 2012;50:17–25. 22946292
16. Tahtay Koraro Woreda Health Office Report. 2016.
17. Afewerki M IT, Ahmed B. Technical report on pyrrolizidine alkaloids induced hepatic veno-occulusive disease (hepatic-VOD) from north western zones of Tigray, Ethiopia Addis Ababa Ethiopian public health association, April 2013.